Position in LLY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,375,746
+$325,369 QoQ
Shares Held
1,147
+0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#2,848
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KLCM Advisors, Inc. holds $30,076,760 across 9 Drug Manufacturers - General names. LLY ranks #6 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
293,739 | $16,925,241 | |
| 2 | PFE |
Pfizer Inc
|
166,401 | $4,006,936 | |
| 3 | ABBV |
AbbVie Inc.
|
10,009 | $2,518,664 | |
| 4 | JNJ |
Johnson & Johnson
|
8,607 | $2,185,919 | |
| 5 | MRK |
Merck & Co., Inc.
|
13,218 | $1,698,513 | |
| 6 | LLY |
ELI LILLY & Co
This page
|
1,147 | $1,375,746 | |
| 7 | OGN |
Organon & Co.
|
48,807 | $660,846 | |
| 8 | AMGN |
Amgen Inc
|
1,343 | $486,327 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,375,746 | 1,147 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,050,377 | 1,142 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $1,426,100 | 1,327 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $1,007,160 | 1,320 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,388,111 | 6,912 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $5,655,005 | 6,847 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $5,285,884 | 6,847 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $6,066,031 | 6,847 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $6,538,654 | 7,222 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,579,529 | 7,172 | Shares | Sole | 2024-05-16 | |
| 2023-12-31 | $4,560,183 | 7,823 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $3,591,251 | 6,686 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $3,066,191 | 6,538 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,139,163 | 6,229 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,245,891 | 6,139 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,968,878 | 6,089 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,959,646 | 6,044 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $1,758,025 | 6,139 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $1,640,470 | 5,939 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $1,325,995 | 5,739 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,317,215 | 5,739 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $1,054,412 | 5,644 | Shares | Sole | 2021-04-21 | |
| 2020-12-31 | $952,932 | 5,644 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $830,836 | 5,613 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $921,542 | 5,613 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $778,635 | 5,613 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||